These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1939785)

  • 1. Analysis of HMB-45 immunoreactivity in common and cellular blue nevi.
    Wood WS; Tron VA
    J Cutan Pathol; 1991 Aug; 18(4):261-3. PubMed ID: 1939785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HMB-45 staining in benign and malignant melanocytic lesions. A reflection of cellular activation.
    Skelton HG; Smith KJ; Barrett TL; Lupton GP; Graham JH
    Am J Dermatopathol; 1991 Dec; 13(6):543-50. PubMed ID: 1725245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Congenital agminated Spitz nevi: immunoreactivity with a melanoma-associated monoclonal antibody.
    Palazzo JP; Duray PH
    J Cutan Pathol; 1988 Jun; 15(3):166-70. PubMed ID: 3397410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Typical, dysplastic, congenital, and Spitz nevi: a comparative immunohistochemical study.
    Palazzo J; Duray PH
    Hum Pathol; 1989 Apr; 20(4):341-6. PubMed ID: 2703228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Contribution of monoclonal antibody HMB45 in the histopathologic diagnosis of melanoma].
    Pluot M; Joundi A; Grosshans E
    Ann Dermatol Venereol; 1990; 117(10):691-9. PubMed ID: 1705764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody HMB-45 identifies the cells of blue nevi. An immunohistochemical study on paraffin sections.
    Sun J; Morton TH; Gown AM
    Am J Surg Pathol; 1990 Aug; 14(8):748-51. PubMed ID: 2378395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compound melanocytic nevi with granular cell changes.
    El-Gamal HM; Robinson-Bostom L; Saddler KD; Pan T; Mihm MC
    J Am Acad Dermatol; 2004 May; 50(5):765-6. PubMed ID: 15097962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral melanocytic lesions: differences in expression of HMB-45 and S-100 antigens in round and spindle cells of malignant and benign lesions.
    Gazit D; Daniels TE
    J Oral Pathol Med; 1994 Feb; 23(2):60-4. PubMed ID: 8164154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
    Nasr MR; El-Zammar O
    Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMB-45 antibody reactivity in pigmented lesions of the conjunctiva.
    Glasgow BJ; McCall LC; Foos RY
    Am J Ophthalmol; 1990 Jun; 109(6):696-700. PubMed ID: 2189315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SM5-1: a new monoclonal antibody which is highly sensitive and specific for melanocytic lesions.
    Trefzer U; Rietz N; Chen Y; Audring H; Herberth G; Siegel P; Reinke S; Königer P; Wu S; Ma J; Liu Y; Wang H; Sterry W; Guo Y
    Arch Dermatol Res; 2000 Dec; 292(12):583-9. PubMed ID: 11214818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nevoid malignant melanoma: morphologic patterns and immunohistochemical reactivity.
    McNutt NS; Urmacher C; Hakimian J; Hoss DM; Lugo J
    J Cutan Pathol; 1995 Dec; 22(6):502-17. PubMed ID: 8835170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HMB-45 staining of dysplastic melanocytic nevi in melanoma risk groups.
    Ahmed I; Piepkorn M; Goldgar DE; Cannon-Albright LA; Meyer LJ; Skolnick MH; Zone JJ
    J Cutan Pathol; 1991 Aug; 18(4):257-60. PubMed ID: 1939784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative immunoreactivity of CD-68 and HMB-45 in malignant melanoma, neural tumors and nevi.
    Shah IA; Gani OS; Wheler L
    Pathol Res Pract; 1997; 193(7):497-502. PubMed ID: 9342756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ex vivo quality-switched ruby laser irradiation of cutaneous melanocytic lesions: persistence of S-100-, HMB-45- and Masson-positive cells.
    Kopera D; Hohenleutner U; Stolz W; Landthaler M
    Dermatology; 1997; 194(4):344-50. PubMed ID: 9252755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Melan-A and Ki-67 in desmoplastic melanoma and desmoplastic nevi.
    Kucher C; Zhang PJ; Pasha T; Elenitsas R; Wu H; Ming ME; Elder DE; Xu X
    Am J Dermatopathol; 2004 Dec; 26(6):452-7. PubMed ID: 15618925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HMB-45 monoclonal antibody recognizes an inducible and reversible melanocyte cytoplasmic protein.
    Smoller BR; Hsu A; Krueger J
    J Cutan Pathol; 1991 Oct; 18(5):315-22. PubMed ID: 1761783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent pigmented melanocytic nevus. A benign lesion, not to be mistaken for malignant melanoma.
    Sexton M; Sexton CW
    Arch Pathol Lab Med; 1991 Feb; 115(2):122-6. PubMed ID: 1992976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S100A6 protein expression is different in Spitz nevi and melanomas.
    Ribé A; McNutt NS
    Mod Pathol; 2003 May; 16(5):505-11. PubMed ID: 12748257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compound blue nevus: a variant of blue nevus with an additional junctional dendritic component. A clinical, histopathologic, and immunohistochemical study of six cases.
    Kamino H; Tam ST
    Arch Dermatol; 1990 Oct; 126(10):1330-3. PubMed ID: 2221938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.